The search for the 2013 Pink Power Moms has begun!

Article

Kathy LaTour blog image

Women who are diagnosed with breast cancer usually do one of two things, they go through treatment and get back to their lives, or they go through treatment, get back to their lives and also get involved in some aspect of breast cancer. Either path is just fine, and I know women who have gone both directions. I needed to get involved. The primary reason I chose to do so was that when I was diagnosed in 1986, there were very few young women out there who were advocating for support once treatment ended. We know now that survivorship services are more than nice, they are essential to our emotional and physical health and well being. I just knew that for me when it was supposedly over – it wasn't over. I had a 1-year-old and I spent the majority of my time reading the obituaries and wondering when I would wake up with a lump somewhere that it wasn't supposed to be. I learned fear was much scarier than surgery. And I also found that when I was doing something for someone else, I wasn't as consumed with fear of recurrence. I also spent a lot of time angry, and being busy tended to keep that under control. At first I was angry at the healthcare system that wasn't providing what I saw as essential, equal services for all women. Then I was angry at cancer when I found out that my daughter might be at risk for breast cancer. When I learned I didn't carry the breast cancer genes, I was just angry that cancer took the lives of so many young women and that we weren't making much headway in learning why. Then I was angry that there weren't any survivorship services. By then the anger had dissolved into passion about educating women and helping women get treatment. Then in 1992 my mother was diagnosed with metastatic breast cancer. She died six months later and I got angry all over again. In 2008 I learned I had been named a Pink Power Mom by The Bright Starts division of Kids II®, national baby and children toys and gear creator that has lines such as Baby Disney and Baby Einstein as well as Bright Starts and Ingenuity. This organization decided to name eight women a year from communities across the nation Pink Power Moms and help support their 501c3 nonprofits with a $5,000 check. I was in the class of 2008 and since then they have named a class each year. Now with six classes, the Pink Power Moms are coming together to support each other in their endeavors with advice and support in their various causes. We also help get the word out when nominations are open for the next class of Pink Power Moms, which is what today's blog is doing. So, this is your chance to get some recognition for that breast cancer survivor mom who has turned her energy toward making a difference. If you are wondering if she is a worthy candidate just go to the Kids II web page and read what the other Pink Power Moms have been up to and decide for yourself. If you think she would make a good Pink Power Mom, nominate her. The eight selected will each get $5,000 for the nonprofit of their choice plus $1,000 a year for five years. They will also get a weekend of pampering in Atlanta in February 2014 where they will meet and discuss their directions for the year.They will also meet the recently formed steering committee to talk about plans for the future. So, get those nominations in.

Related Videos
For patients with cancer, the ongoing chemotherapy shortage may cause some anxiety as they wonder how they will receive their drugs. However, measuring drugs “down to the minutiae of the milligrams” helped patients receive the drugs they needed, said Alison Tray. Tray is an advanced oncology certified nurse practitioner and current vice president of ambulatory operations at Rutgers Cancer Institute in New Jersey.  If patients are concerned about getting their cancer drugs, Tray noted that having “an open conversation” between patients and providers is key.  “As a provider and a nurse myself, having that conversation, that reassurance and sharing the information is a two-way conversation,” she said. “So just knowing that we're taking care of you, we're going to make sure that you receive the care that you need is the key takeaway.” In June 2023, many patients were unable to receive certain chemotherapy drugs, such as carboplatin and cisplatin because of an ongoing shortage. By October 2023, experts saw an improvement, although the “ongoing crisis” remained.  READ MORE: Patients With Lung Cancer Face Unmet Needs During Drug Shortages “We’re really proud of the work that we could do and achieve that through a critical drug shortage,” Tray said. “None of our patients missed a dose of chemotherapy and we were able to provide that for them.” Tray sat down with CURE® during the 49th Annual Oncology Nursing Society Annual Congress to discuss the ongoing chemo shortage and how patients and care teams approached these challenges. Transcript: Particularly at Hartford HealthCare, when we established this infrastructure, our goal was to make sure that every patient would get the treatment that they need and require, utilizing the data that we have from ASCO guidelines to ensure that we're getting the optimal high-quality standard of care in a timely fashion that we didn't have to delay therapies. So, we were able to do that by going down to the minutiae of the milligrams on hand, particularly when we had a lot of critical drug shortages. So it was really creating that process to really ensure that every patient would get the treatment that they needed. For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.
Yuliya P.L Linhares, MD, an expert on CLL
Yuliya P.L Linhares, MD, and Josie Montegaard, MSN, AGPCNP-BC, experts on CLL
Image of a man with a beard.
Image of a man with gray facial hair and a navy blue suit with a light orange tie.
Image of a woman with black hair.
Related Content